Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
2,129,751
-
Shares change
-
-36,581
-
Total reported value, excl. options
-
$101,049,767
-
Value change
-
-$2,207,669
-
Number of buys
-
21
-
Number of sells
-
-38
-
Price
-
$47.43
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2021
87 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q3 2021.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,129,751 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (626,458 shares), MORGAN STANLEY (402,995 shares), BANK OF AMERICA CORP /DE/ (253,208 shares), BNP PARIBAS ARBITRAGE, SA (103,703 shares), LPL Financial LLC (78,750 shares), Hochman Cole Investment Advisors, Inc. (52,630 shares), ROYAL BANK OF CANADA (50,345 shares), FIRST CITIZENS BANK & TRUST CO (45,738 shares), WELLS FARGO & COMPANY/MN (44,124 shares), and Private Advisor Group, LLC (42,842 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.